AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
4.010
-0.240 (-5.65%)
At close: Jul 11, 2025, 4:00 PM
4.100
+0.090 (2.24%)
After-hours: Jul 11, 2025, 7:59 PM EDT

AbCellera Biologics (ABCL) Revenue by Segment

History

Date Research Fees Licensing Milestone Payments Royalty
Mar 31, 2025 20.58M 1.04M - -
Dec 31, 2024 26.28M 1.05M - -
Sep 30, 2024 30.26M 953.00K - -
Jun 30, 2024 30.38M 921.00K 1.75M -
Mar 31, 2024 34.76M 777.00K - -
Dec 31, 2023 35.56M 969.00K 1.50M -
Sep 30, 2023 38.24M 948.00K - -
Jun 30, 2023 39.33M 916.00K - -
Mar 31, 2023 42.04M 837.00K 2.15M -
Dec 31, 2022 40.80M 696.00K 900.00K 443.03M
Sep 30, 2022 34.13M 598.00K 400.00K 568.07M
Jun 30, 2022 31.75M 634.00K - 474.94M
Mar 31, 2022 24.42M 750.00K - 462.87M
Dec 31, 2021 19.08M 20.78M - 327.35M
Sep 30, 2021 16.93M 20.71M - 391.16M
Jun 30, 2021 16.16M 20.52M 21.00M 390.97M
Mar 31, 2021 19.18M 20.26M 23.00M 369.80M
Dec 31, 2020 19.85M - 16.00M 198.31M
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.